Ken Aldape

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

Heidi Phillips, Samir Kharbanda, Ruihuan Chen et al. · Cancer Cell · 2006 · 3.2K citations · Full text

Neuro-oncology, Disease Progression, Tumor Heterogeneity +15

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

Jay E. Brenman, Daniel S. Chao, Houhui Xia et al. · Cell · 1995 · 958 citations · Full text

Biochemistry, Duchenne Muscular Dystrophy, Pathology +2

Transforming Fusions of <i>FGFR</i> and <i>TACC</i> Genes in Human Glioblastoma

Devendra Raj Singh, Joseph M. Chan, Pietro Zoppoli et al. · Science · 2012 · 757 citations · Full text

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Yu Liang, Maximilian Diehn, Nathan P. Watson et al. · Proceedings of the National Academy of Sciences · 2005 · 497 citations · Full text

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge et al. · The Lancet · 2017 · 392 citations · Full text

Catnon Trial, Treatment Strategies, Radiation Therapy +13